Scientists are pioneering mitochondrial transplants that replace damaged cellular powerhouses with healthy ones, showing promise for treating Parkinson's, heart failure, stroke, and aging itself—with first clinical trials launching now.
Mitochondrial transplantation—replacing damaged cellular powerhouses with healthy ones—is moving from experimental labs to clinical reality. Eight babies born via mitochondrial replacement therapy are thriving, while cardiac patients are recovering after direct mitochondrial injections. This breakthrough treats rare genetic disorders, heart disease, and potentially aging itself, with the global market projected to reach $1 billion by 2035. Yet challenges remain: long-term safety, ethical conc...
Loading featured articles...